Why the FDA Doesn’t Support Covid Boosters Forever

Marty Makary is a surgical oncologist, a former faculty member at the Johns Hopkins University School of Medicine, and the Commissioner of the Food and Drug Administration (FDA).

In this commentary, Makary explains why the FDA is "shifting to a risk-tiered approach" on COVID-19 vaccines.